Mayflower Medicinals Opens Flagship Cannabis Dispensary in Boston
NEW YORK and TORONTO, July 19, 2018 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with licensed cannabis operations throughout the United States, is pleased to announce that Mayflower Medicinals, Inc. (“Mayflower”), a Massachusetts non-profit Registered Marijuana Dispensary (“RMD”) license holder affiliated with the Company, is opening its flagship medical cannabis dispensary in Boston.
Located in the neighborhood of Allston, the dispensary will offer patients a full spectrum of medical cannabis products in the form of flower, tinctures, concentrates, oils and vaporizers. Mayflower is the second license holder to open a dispensary within the city of Boston. This inaugural Mayflower location is the 34th dispensary to open within the commonwealth of Massachusetts, which has a population of approximately 6.7 million people.
As we open the doors to our new dispensary, we look forward to taking on an overarching responsibility to provide patients with cannabis-based therapeutic products for alleviation of medical symptoms. Our dispensary agents have undergone extensive training on products, consumption methods and the endocannabinoid system, and will act as a reliable source for cannabis education for the public. We look forward to further developing a relationship with the community of Boston and adding both jobs and revenue to the community.
Hadley Ford, CEO and co-founder of iAnthus
The new dispensary will be supplied by Mayflowers’ fully operational cultivation and processing facility located in Holliston, Massachusetts. The 36,000 sq. ft. facility has the capability to produce up to 2,625 kg of product annually and has been cultivating product since January 2018.
Mayflower launched its Patient Home Delivery Program on June 25 which now services the towns of Arlington, Boston, Brookline, Cambridge, Charleston, Chelsea, East Boston, Everett, Malden, Medford, Milton, Quincy, Revere, Somerville and Watertown.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company uses these skills to support operations across six states. For more information, visit www.iAnthusCapital.com.
About Mayflower Medicinals, Inc.
Mayflower Medicinals is a “patient-first” non-profit healthcare organization, dedicated to providing the highest-quality medical cannabis products and services in a safe, secure and professionally managed environment in the Commonwealth of Massachusetts. Mayflower has received a final license for its Boston Dispensary and Hollistoncultivation and production facility, as well as a provisional license for an additional RMD. Mayflower has a third application for an RMD license pending. Mayflower is affiliated with iAnthus Capital Management, LLC and Randy Maslow, Hadley Ford and John Henderson of iAnthus are members of the five-person Mayflower Board of Directors.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.